{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:49:48Z","timestamp":1785901788552,"version":"3.56.0"},"reference-count":80,"publisher":"The Company of Biologists","issue":"6","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2021R1C1C2004658"],"award-info":[{"award-number":["NRF-2021R1C1C2004658"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["RS-2023-00234175"],"award-info":[{"award-number":["RS-2023-00234175"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["NRF-2020R1I1A3073861"],"award-info":[{"award-number":["NRF-2020R1I1A3073861"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002456","name":"Chonnam National University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002456","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Epilepsy is a neurological disorder associated with abnormal neuronal activity in the central nervous system, resulting in recurrent seizures. Various anti-seizure medications (ASMs) are effective against epilepsy. However, approximately one-third of patients still do not respond to currently available ASMs either alone or in combination because the etiology of their epilepsy remains unclear. To create a novel zebrafish epilepsy model, we analyzed the exomes of 400 Korean patients with epilepsy via whole-exome sequencing. We found 39 candidate genes and investigated these genes through in situ hybridization and loss-of-function studies, identifying SLC25A22, encoding a mitochondrial glutamate carrier, as a potential epilepsy gene. Subsequently, we generated zebrafish slc25a22a mutants and observed that they displayed spontaneous seizures, high-voltage deflections in local field potentials, and elevated Ca2+ levels propagating from the forebrain to the spinal cord. Of nine ASMs tested, valproic acid (VPA) was able to suppress spontaneous seizure activities in slc25a22a mutant larvae, highlighting the unique anti-seizure effect of VPA in this model. Our findings provide valuable insights into the pathogenesis of epilepsy and suggest slc25a22a as a potential target for novel ASM development.<\/jats:p>","DOI":"10.1242\/dmm.052275","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T20:13:48Z","timestamp":1750796028000},"source":"Crossref","is-referenced-by-count":5,"title":["Mutant zebrafish lacking <i>slc25a22a<\/i> show spontaneous seizures and respond to the anti-seizure medication valproic acid"],"prefix":"10.1242","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9992-6038","authenticated-orcid":false,"given":"So-Hyun","family":"Lee","sequence":"first","affiliation":[{"name":"Chonnam National University Medical School 1 Department of Biomedical Sciences , , Hwasun 58128 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Liang","sequence":"additional","affiliation":[{"name":"Chonnam National University Medical School 1 Department of Biomedical Sciences , , Hwasun 58128 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopalakrishnan","family":"Chandrasekaran","sequence":"additional","affiliation":[{"name":"Chonnam National University Medical School 1 Department of Biomedical Sciences , , Hwasun 58128 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tangdu Hospital, Fourth Military Medical University 2 Department of Neurology , , Xi'an 710038 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Soon","family":"Kim","sequence":"additional","affiliation":[{"name":"Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology (KRICT) 3 , Daejeon 34114 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundareswaran Varier","family":"Parvathi","sequence":"additional","affiliation":[{"name":"Chonnam National University Medical School 1 Department of Biomedical Sciences , , Hwasun 58128 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Won","family":"Lee","sequence":"additional","affiliation":[{"name":"Chonnam National University Medical School 1 Department of Biomedical Sciences , , Hwasun 58128 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Seo","family":"Cho","sequence":"additional","affiliation":[{"name":"School of Electrical Engineering, 4 Korea Advanced Institute of Science and Technology ( ), Daejeon 34141 ,","place":["Republic of Korea"]},{"name":"KAIST 4 Korea Advanced Institute of Science and Technology ( ), Daejeon 34141 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Young","family":"Shin","sequence":"additional","affiliation":[{"name":"Chonnam National University Medical School 1 Department of Biomedical Sciences , , Hwasun 58128 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Gyu","family":"Yoon","sequence":"additional","affiliation":[{"name":"School of Electrical Engineering, 4 Korea Advanced Institute of Science and Technology ( ), Daejeon 34141 ,","place":["Republic of Korea"]},{"name":"KAIST 4 Korea Advanced Institute of Science and Technology ( ), Daejeon 34141 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihoon","family":"Jo","sequence":"additional","affiliation":[{"name":"Chonnam National University Medical School 1 Department of Biomedical Sciences , , Hwasun 58128 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ae","family":"Bae","sequence":"additional","affiliation":[{"name":"Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology (KRICT) 3 , Daejeon 34114 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7193-292X","authenticated-orcid":false,"given":"Seok-Yong","family":"Choi","sequence":"additional","affiliation":[{"name":"Chonnam National University Medical School 1 Department of Biomedical Sciences , , Hwasun 58128 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8673-7561","authenticated-orcid":false,"given":"Myeong-Kyu","family":"Kim","sequence":"additional","affiliation":[{"name":"Chonnam National University Medical School 5 Department of Neurology , , Gwangju 61469 ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"2025062510134436800_DMM052275C1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2147\/NDT.S2937","article-title":"Levetiracetam in the treatment of epilepsy","volume":"4","author":"Abou-Khalil","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"2025062510134436800_DMM052275C2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.arcped.2020.10.015","article-title":"The phenotype caused by recessive variations in SLC25A22: report of a new case and literature review","volume":"28","author":"Andre","year":"2021","journal-title":"Arch. Pediatr."},{"key":"2025062510134436800_DMM052275C3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1046\/j.1471-4159.2003.02186.x","article-title":"Topiramate modulation of kainate-induced calcium currents is inversely related to channel phosphorylation level","volume":"88","author":"Angehagen","year":"2004","journal-title":"J. Neurochem."},{"key":"2025062510134436800_DMM052275C4","doi-asserted-by":"publisher","first-page":"50104","DOI":"10.3791\/50104","article-title":"Forebrain electrophysiological recording in larval zebrafish","volume":"71","author":"Baraban","year":"2013","journal-title":"J. Vis. Exp."},{"key":"2025062510134436800_DMM052275C5","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1038\/ncomms3410","article-title":"Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment","volume":"4","author":"Baraban","year":"2013","journal-title":"Nat. Commun."},{"key":"2025062510134436800_DMM052275C6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1113\/jphysiol.1991.sp018545","article-title":"Electrogenic uptake of glutamate and aspartate into glial cells isolated from the salamander (Ambystoma) retina","volume":"436","author":"Barbour","year":"1991","journal-title":"J. Physiol."},{"key":"2025062510134436800_DMM052275C7","doi-asserted-by":"publisher","first-page":"a022863","DOI":"10.1101\/cshperspect.a022863","article-title":"Glutamatergic mechanisms associated with seizures and epilepsy","volume":"5","author":"Barker-Haliski","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2025062510134436800_DMM052275C8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1471-4159.1975.tb06953.x","article-title":"Metabolism of amino acids and ammonia in rat brain cortex slices in vitro: a possible role of ammonia in brain function","volume":"25","author":"Benjamin","year":"1975","journal-title":"J. Neurochem."},{"key":"2025062510134436800_DMM052275C9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"2025062510134436800_DMM052275C10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejpn.2020.01.006","article-title":"Imaging epilepsy in larval zebrafish","volume":"24","author":"Burrows","year":"2020","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"2025062510134436800_DMM052275C11","doi-asserted-by":"publisher","first-page":"479364","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Chateauvieux","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"2025062510134436800_DMM052275C12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ntt.2018.01.002","article-title":"Developmental and behavioral alterations in zebrafish embryonically exposed to valproic acid (VPA): an aquatic model for autism","volume":"66","author":"Chen","year":"2018","journal-title":"Neurotoxicol. Teratol."},{"key":"2025062510134436800_DMM052275C13","doi-asserted-by":"publisher","first-page":"e50644","DOI":"10.3791\/50644","article-title":"High resolution whole mount in situ hybridization within zebrafish embryos to study gene expression and function","volume":"80","author":"Chitramuthu","year":"2013","journal-title":"J. Vis. Exp."},{"key":"2025062510134436800_DMM052275C14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s42826-021-00103-2","article-title":"Transgenic fluorescent zebrafish lines that have revolutionized biomedical research","volume":"37","author":"Choe","year":"2021","journal-title":"Lab. Anim. Res."},{"key":"2025062510134436800_DMM052275C15","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.3390\/ijms24076050","article-title":"Understanding Lamotrigine's role in the CNS and possible future evolution","volume":"24","author":"Costa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"2025062510134436800_DMM052275C16","doi-asserted-by":"publisher","first-page":"7702","DOI":"10.3390\/ijms24097702","article-title":"Zebrafish as an innovative tool for epilepsy modeling: state of the art and potential future directions","volume":"24","author":"D'Amora","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"2025062510134436800_DMM052275C17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.pharmthera.2004.10.004","article-title":"Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy","volume":"105","author":"Delorenzo","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"2025062510134436800_DMM052275C18","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/aur.3010","article-title":"Zebrafish embryonically exposed to valproic acid present impaired retinal development and sleep behavior","volume":"16","author":"Deoliveira-Mello","year":"2023","journal-title":"Autism. Res."},{"key":"2025062510134436800_DMM052275C19","doi-asserted-by":"publisher","first-page":"18024","DOI":"10.1038\/nrdp.2018.24","article-title":"Epilepsy","volume":"4","author":"Devinsky","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2025062510134436800_DMM052275C20","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1111\/epi.17659","article-title":"kcna1a mutant zebrafish model episodic ataxia type 1 (EA1) with epilepsy and show response to first-line therapy carbamazepine","volume":"64","author":"Dogra","year":"2023","journal-title":"Epilepsia"},{"key":"2025062510134436800_DMM052275C21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0140-6736(03)15166-5","article-title":"Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy","volume":"363","author":"Eid","year":"2004","journal-title":"Lancet"},{"key":"2025062510134436800_DMM052275C22","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/nprot.2006.230","article-title":"Evaluating the biological relevance of putative enhancers using Tol2 transposon-mediated transgenesis in zebrafish","volume":"1","author":"Fisher","year":"2006","journal-title":"Nat. Protoc."},{"key":"2025062510134436800_DMM052275C23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"2025062510134436800_DMM052275C24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.pcl.2005.09.010","article-title":"Seizures in children","volume":"53","author":"Friedman","year":"2006","journal-title":"Pediatr. Clin. North Am."},{"key":"2025062510134436800_DMM052275C25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neubiorev.2020.06.010","article-title":"Seizing the moment: zebrafish epilepsy models","volume":"116","author":"Gawel","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"2025062510134436800_DMM052275C26","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1007\/s12035-019-01860-x","article-title":"Phenotypic characterization of larval zebrafish (Danio rerio) with partial knockdown of the cacna1a gene.","volume":"57","author":"Gawel","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"2025062510134436800_DMM052275C27","doi-asserted-by":"publisher","first-page":"1418606","DOI":"10.3389\/fnmol.2024.1418606","article-title":"Induction of seizures and initiation of epileptogenesis by pilocarpine in zebrafish larvae","volume":"17","author":"Gawel","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"2025062510134436800_DMM052275C28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: pharmacokinetics and pharmacodynamics","volume":"23","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharmacogenet. Genomics"},{"key":"2025062510134436800_DMM052275C29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.seizure.2019.06.029","article-title":"Severe early-onset developmental and epileptic encephalopathy (DEE) associated with novel compound heterozygous pathogenic variants in SLC25A22: case report and literature review","volume":"70","author":"Giacomini","year":"2019","journal-title":"Seizure"},{"key":"2025062510134436800_DMM052275C30","doi-asserted-by":"publisher","first-page":"e818","DOI":"10.1038\/tp.2016.88","article-title":"Developmental suppression of schizophrenia-associated miR-137 alters sensorimotor function in zebrafish","volume":"6","author":"Giacomotto","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"2025062510134436800_DMM052275C31","first-page":"392","article-title":"Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment","volume":"35","author":"Goldenberg","year":"2010","journal-title":"P. T."},{"key":"2025062510134436800_DMM052275C32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fncel.2017.00149","article-title":"Inhibition of the mitochondrial glutamate carrier SLC25A22 in astrocytes leads to intracellular glutamate accumulation","volume":"11","author":"Goubert","year":"2017","journal-title":"Front. Cell Neurosci."},{"key":"2025062510134436800_DMM052275C33","doi-asserted-by":"publisher","first-page":"114786","DOI":"10.1016\/j.bcp.2021.114786","article-title":"Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: opportunities for novel therapeutics development","volume":"193","author":"Green","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"2025062510134436800_DMM052275C34","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/s42003-021-02221-y","article-title":"Phenotypic analysis of catastrophic childhood epilepsy genes","volume":"4","author":"Griffin","year":"2021","journal-title":"Commun. Biol."},{"key":"2025062510134436800_DMM052275C35","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa050456","article-title":"Congenital glutamine deficiency with glutamine synthetase mutations","volume":"353","author":"Haberle","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"2025062510134436800_DMM052275C36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ymgme.2011.02.001","article-title":"Natural course of glutamine synthetase deficiency in a 3 year old patient","volume":"103","author":"Haberle","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"2025062510134436800_DMM052275C37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/glia.24106","article-title":"Loss of glutamate transporter eaat2a leads to aberrant neuronal excitability, recurrent epileptic seizures, and basal hypoactivity","volume":"70","author":"Hotz","year":"2022","journal-title":"Glia"},{"key":"2025062510134436800_DMM052275C38","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nbt.2501","article-title":"Efficient genome editing in zebrafish using a CRISPR-Cas system","volume":"31","author":"Hwang","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"2025062510134436800_DMM052275C39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1089\/zeb.2022.0015","article-title":"A rapid and noninvasive method that extracts polymerase chain reaction-ready genomic DNA from adult zebrafish","volume":"19","author":"Jang","year":"2022","journal-title":"Zebrafish"},{"key":"2025062510134436800_DMM052275C40","doi-asserted-by":"publisher","first-page":"13904","DOI":"10.1073\/pnas.1308335110","article-title":"Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system","volume":"110","author":"Jao","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025062510134436800_DMM052275C41","doi-asserted-by":"publisher","first-page":"29409","DOI":"10.1074\/jbc.M313120200","article-title":"Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation","volume":"279","author":"Jin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2025062510134436800_DMM052275C80","doi-asserted-by":"publisher","first-page":"baz146","DOI":"10.1093\/database\/baz146","article-title":"KRGDB: the large-scale variant database of 1722 Koreans based on whole genome sequencing","volume":"2020","author":"Jung","year":"2020","journal-title":"Database"},{"key":"2025062510134436800_DMM052275C42","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3988\/jcn.2022.18.5.553","article-title":"Multidimensional early prediction score for drug-resistant epilepsy","volume":"18","author":"Kang","year":"2022","journal-title":"J. Clin. Neurol."},{"key":"2025062510134436800_DMM052275C43","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/TCRM.S5189","article-title":"Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety","volume":"5","author":"Kellinghaus","year":"2009","journal-title":"Ther. Clin. Risk Manag."},{"key":"2025062510134436800_DMM052275C44","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2144\/000112909","article-title":"Real-time imaging of mitochondria in transgenic zebrafish expressing mitochondrially targeted GFP","volume":"45","author":"Kim","year":"2008","journal-title":"BioTechniques"},{"key":"2025062510134436800_DMM052275C45","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/aja.1002030302","article-title":"Stages of embryonic development of the zebrafish","volume":"203","author":"Kimmel","year":"1995","journal-title":"Dev. Dyn."},{"key":"2025062510134436800_DMM052275C46","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1046\/j.1471-4159.1995.65020871.x","article-title":"Glutamine from glial cells is essential for the maintenance of the nerve terminal pool of glutamate: immunogold evidence from hippocampal slice cultures","volume":"65","author":"Laake","year":"1995","journal-title":"J. Neurochem."},{"key":"2025062510134436800_DMM052275C47","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/s41431-019-0433-2","article-title":"Report on three additional patients and genotype-phenotype correlation in SLC25A22-related disorders group","volume":"27","author":"Lemattre","year":"2019","journal-title":"Eur. J. Hum. Genet."},{"key":"2025062510134436800_DMM052275C48","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1007\/s11064-021-03358-2","article-title":"Efficacy of fenfluramine and norfenfluramine enantiomers and various antiepileptic drugs in a zebrafish model of Dravet syndrome","volume":"46","author":"Li","year":"2021","journal-title":"Neurochem. Res."},{"key":"2025062510134436800_DMM052275C49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12883-021-02395-2","article-title":"Response to Sodium Channel blocking Antiseizure medications and coding polymorphisms of Sodium Channel genes in Taiwanese epilepsy patients","volume":"21","author":"Lin","year":"2021","journal-title":"BMC Neurol."},{"key":"2025062510134436800_DMM052275C50","first-page":"1813","article-title":"Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging","volume":"22","author":"Mark","year":"2001","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"2025062510134436800_DMM052275C51","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1086\/427564","article-title":"Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy","volume":"76","author":"Molinari","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"2025062510134436800_DMM052275C52","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1399-0004.2009.01236.x","article-title":"Mutations in the mitochondrial glutamate carrier SLC25A22 in neonatal epileptic encephalopathy with suppression bursts","volume":"76","author":"Molinari","year":"2009","journal-title":"Clin. Genet."},{"key":"2025062510134436800_DMM052275C53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/01677063.2021.1892094","article-title":"De novo mutation in SLC25A22 gene: expansion of the clinical and electroencephalographic phenotype","volume":"35","author":"Nicotera","year":"2021","journal-title":"J. Neurogenet."},{"key":"2025062510134436800_DMM052275C54","doi-asserted-by":"publisher","first-page":"7099","DOI":"10.1523\/JNEUROSCI.18-18-07099.1998","article-title":"Anion currents and predicted glutamate flux through a neuronal glutamate transporter","volume":"18","author":"Otis","year":"1998","journal-title":"J. Neurosci."},{"key":"2025062510134436800_DMM052275C55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.nbd.2012.05.010","article-title":"Evidence for astrocytes as a potential source of the glutamate excess in temporal lobe epilepsy","volume":"47","author":"Perez","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"2025062510134436800_DMM052275C56","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.23998","article-title":"SLC25A22 is a novel gene for migrating partial seizures in infancy","volume":"74","author":"Poduri","year":"2013","journal-title":"Ann. Neurol."},{"key":"2025062510134436800_DMM052275C57","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10545-017-0025-7","article-title":"Mutations in SLC25A22: hyperprolinaemia, vacuolated fibroblasts and presentation with developmental delay","volume":"40","author":"Reid","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"2025062510134436800_DMM052275C58","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.cub.2014.07.080","article-title":"The retinal projectome reveals brain-area-specific visual representations generated by ganglion cell diversity","volume":"24","author":"Robles","year":"2014","journal-title":"Curr. Biol."},{"key":"2025062510134436800_DMM052275C59","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.neuint.2012.02.013","article-title":"Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control","volume":"61","author":"Rowley","year":"2012","journal-title":"Neurochem. Int."},{"key":"2025062510134436800_DMM052275C60","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1111\/epi.14576","article-title":"gamma-Aminobutyric acid receptor alpha 1 subunit loss of function causes genetic generalized epilepsy by impairing inhibitory network neurodevelopment","volume":"59","author":"Samarut","year":"2018","journal-title":"Epilepsia"},{"key":"2025062510134436800_DMM052275C61","doi-asserted-by":"publisher","first-page":"W599","DOI":"10.1093\/nar\/gkm349","article-title":"Zinc Finger Targeter (ZiFiT): an engineered zinc finger\/target site design tool","volume":"35","author":"Sander","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"2025062510134436800_DMM052275C62","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.seizure.2021.06.028","article-title":"Brain concentrations of glutamate and GABA in human epilepsy: a review","volume":"91","author":"Sarlo","year":"2021","journal-title":"Seizure"},{"key":"2025062510134436800_DMM052275C63","doi-asserted-by":"publisher","first-page":"107966","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"key":"2025062510134436800_DMM052275C64","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00401-022-02429-0","article-title":"SCN1A overexpression, associated with a genomic region marked by a risk variant for a common epilepsy, raises seizure susceptibility","volume":"144","author":"Silvennoinen","year":"2022","journal-title":"Acta Neuropathol."},{"key":"2025062510134436800_DMM052275C65","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.ncl.2016.06.015","article-title":"The Epidemiology of Global Epilepsy","volume":"34","author":"Singh","year":"2016","journal-title":"Neurol. Clin."},{"key":"2025062510134436800_DMM052275C66","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1111\/epi.14647","article-title":"Drug repurposing for Dravet syndrome in scn1Lab(-\/-) mutant zebrafish","volume":"60","author":"Sourbron","year":"2019","journal-title":"Epilepsia"},{"key":"2025062510134436800_DMM052275C67","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.cub.2018.04.061","article-title":"Non-canonical mTOR-independent role of DEPDC5 in regulating GABAergic network development","volume":"28","author":"Swaminathan","year":"2018","journal-title":"Curr. Biol."},{"key":"2025062510134436800_DMM052275C68","doi-asserted-by":"publisher","first-page":"7904","DOI":"10.1038\/s41598-019-44264-6","article-title":"Target identification, screening and in vivo evaluation of pyrrolone-fused benzosuberene compounds against human epilepsy using Zebrafish model of pentylenetetrazol-induced seizures","volume":"9","author":"Tanwar","year":"2019","journal-title":"Sci. Rep."},{"key":"2025062510134436800_DMM052275C69","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/epi.16456","article-title":"New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome","volume":"61","author":"Tiraboschi","year":"2020","journal-title":"Epilepsia"},{"key":"2025062510134436800_DMM052275C70","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1046\/j.1528-1157.2001.042suppl.3008.x","article-title":"GABAergic mechanisms in epilepsy","volume":"42","author":"Treiman","year":"2001","journal-title":"Epilepsia"},{"key":"2025062510134436800_DMM052275C71","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nrn2274","article-title":"Glutamate transporters: confining runaway excitation by shaping synaptic transmission","volume":"8","author":"Tzingounis","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"2025062510134436800_DMM052275C72","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1042\/bj1230211","article-title":"A simulation study of brain compartments. Metabolism of glutamate and related substances in mouse brain","volume":"123","author":"Van Den Berg","year":"1971","journal-title":"Biochem. J."},{"key":"2025062510134436800_DMM052275C73","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.seizure.2016.11.030","article-title":"Epilepsy-associated genes","volume":"44","author":"Wang","year":"2017","journal-title":"Seizure"},{"key":"2025062510134436800_DMM052275C74","doi-asserted-by":"publisher","first-page":"e0219106","DOI":"10.1371\/journal.pone.0219106","article-title":"NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet Syndrome","volume":"15","author":"Weuring","year":"2020","journal-title":"PLoS ONE"},{"key":"2025062510134436800_DMM052275C75","doi-asserted-by":"publisher","first-page":"fcae135","DOI":"10.1093\/braincomms\/fcae135","article-title":"Testing of putative antiseizure drugs in a preclinical Dravet syndrome zebrafish model","volume":"6","author":"Whyte-Fagundes","year":"2024","journal-title":"Brain Commun."},{"key":"2025062510134436800_DMM052275C76","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1111\/febs.15694","article-title":"Past, present and future of zebrafish in epilepsy research","volume":"288","author":"Yaksi","year":"2021","journal-title":"FEBS J."},{"key":"2025062510134436800_DMM052275C77","doi-asserted-by":"publisher","first-page":"881933","DOI":"10.3389\/fnmol.2022.881933","article-title":"Connectivity mapping using a novel sv2a loss-of-function zebrafish epilepsy model as a powerful strategy for anti-epileptic drug discovery","volume":"15","author":"Zhang","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"2025062510134436800_DMM052275C78","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","article-title":"Glutamate as a neurotransmitter in the healthy brain","volume":"121","author":"Zhou","year":"2014","journal-title":"J. Neural. Transm."},{"key":"2025062510134436800_DMM052275C79","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1474-4422(15)00148-9","article-title":"Mitochondrial dysfunction and seizures: the neuronal energy crisis","volume":"14","author":"Zsurka","year":"2015","journal-title":"Lancet Neurol."}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.052275\/3653031\/dmm052275.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.052275\/3653031\/dmm052275.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T14:13:48Z","timestamp":1750860828000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/18\/6\/dmm052275\/368325\/Mutant-zebrafish-lacking-slc25a22a-show"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,1]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.1242\/dmm.052275","relation":{},"ISSN":["1754-8403","1754-8411"],"issn-type":[{"value":"1754-8403","type":"print"},{"value":"1754-8411","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,1]]},"article-number":"dmm052275"}}